“…In the past two decades, biocompatible polymers have attracted great attention in the field of medical applications, such as drug delivery, gene therapy, surface coatings, and tissue engineering. , Amphiphilic and biodegradable polymers are attractive candidates for drug delivery systems with potential to improve drug circulation time, increase drug solubility, and reduce toxicity and side effect. , Among a large family of these polymers, nonionic triblock copolymers composed of poly(propylene oxide) (PPO) hydrophobic midblock and two poly(ethylene oxide) (PEO) hydrophilic end blocks (PEO–PPO–PEO, commercially known as Pluronic or Poloxamer) are of particular interest for properties of adsorption, self-assembly, and micellization. − More recently, PEO–PPO–PEO has been found to be able to seal damaged cell membrane with low toxicity, which is probably due to its surface activity and adsorption capacity into the bilayer of the damaged cell. , …”